Besides just being called international, amg really is an internationally based company, operating in more than 25 markets worldwide. A network of amg subsidiary companies and experienced distributors ensures the availability of our products. Marketing activities are focussed of a number of core geographical regions, such as Europe, Eastern Europe, Far East, Middle East and South America.

amg products have already achieved considerable market share in many markets and rank among the leading products in their segment, a result which demonstrates the strength of amg’s product development and marketing skills.

Regular attendance at international exhibitions has been an important contributory
factor to amg’s successful global expansion. This has also helped to establish amg’s international reputation as a reliable manufacturer of high quality products. The EuroPCR in Barcelona, the European Society of Cardiology Meeting in Vienna and the German Society of Cardiology Meeting in Mannheim were just some of the most important international congresses where amg exhibited in 2008.

amg’s strategy of consistently strong growth through new product launches and
geographical expansion will continue to be a vital success factor in the future. Angioflux/Easyflux, ISTAR/Psion and MAC 4 are all new products, which have been launched during the period 2008/2009. amg has already successfully distributed its products for many years through partner companies in China and South-East Asia – other growth markets, such as India, Japan and Brazil, are being added all the time.
See our Distributors list.